Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) experiencing acute coronary syndromes (ACS) are at high risk for clinical events. In the Platelet Inhibition and Patient Outcomes (PLATO) trial, ticagrelor versus clopidogrel reduced the primary endpoint of death from vascular ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Andell, Pontus, James, Stefan K., Cannon, Christopher P., Cyr, Derek D., Himmelmann, Anders, Husted, Steen, Keltai, Matyas, Koul, Sasha, Santoso, Anwar, Steg, Ph. Gabriel, Storey, Robert F., Wallentin, Lars, Erlinge, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845124/
https://www.ncbi.nlm.nih.gov/pubmed/26452988
http://dx.doi.org/10.1161/JAHA.115.002490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845124/
https://www.ncbi.nlm.nih.gov/pubmed/26452988
http://dx.doi.org/10.1161/JAHA.115.002490

Ejemplares similares